Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-Label Phase II Extension Study of MIV-711 in Knee Osteoarthritis
2016-001096-73Phase 2Completed
- Sponsor
- Medivir
- Start
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of MIV-711 in knee osteoarthritis (OA), sponsored by Medivir. Primary endpoint: Primary Endpoint (Study Population A). Started Aug 2016; status: completed.
02
Drugs
MIV-711
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2016-001096-73.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001096-73.